Moreover, it has been proposed that the polymorphism plays a direct role in the pathogenesis of the disorders by decreasing the expression and synthesis of CCK peptides. The significance of these findings is still unclear and other studies have failed to demonstrate linkage between the polymorphism and alcoholism.
Therefore, CCK has been implicated in a variety of CNS functions-such as feeding behavior, anxiety, analgesia and memory functions as well as psychiatric disease like panic disorder and schizophrenia (for review, see 2, 3 ). Recently, a number of studies have indicated that a C −36 to T transition in the CCK gene promoter Sp1 element 4 ( Figure 1 ) is associated with alcoholism and withdrawal symptoms as well as panic disorder.
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Moreover, it has been proposed that the polymorphism plays a direct role in the pathogenesis of the disorders by decreasing the expression and synthesis of CCK peptides. The significance of these findings is still unclear and other studies have failed to demonstrate linkage between the polymorphism and alcoholism. 8 In this study we examined the function of the C −36 to T transition in transcription of the human CCK gene. We demonstrate that substitution of the C −36 residue causes a slight reduction of Sp1 and Sp3 binding, but this has no effect on transcription in vivo. Moreover, no difference in the response to physiological stimuli was observed. Taken together the results show that the C to T polymorphism does not play a direct role in the pathogenesis of either alcoholism or panic disorder and that a putative association to these disorders is likely to be the result of co-segregation with a linked mutation. Molecular Psychiatry (2000) 5, 443-447.
The binding of trans-acting factors to the CCK Sp1 GGGCGG element and the CCK Sp1-T variant was examined by mobility-shift analysis (Figure 2 ). Follow- Figure 1 Structure of the proximal region of the human CCK promoter. 4 The E-box, CRE/TRE, Sp1 and TATA box elements are indicated. The asterisk indicates the position of the C −36 to T transition and the arrow designates the site of transcriptional initiation.
ing incubation of crude nuclear extracts with labelled CCKSp1-C or CCKSp1-T oligonucleotide probes, two major DNA-protein complexes were formed (panel a, lanes 1 and 5). The upper and lower bands were supershifted with anti-Sp1 or anti-Sp3 antibodies, respectively (panel a, lanes 2-4 and 6-8). To determine the relative binding affinity of Sp1 and Sp3 to the two elements, the factors were displaced with increasing amounts of unlabelled CCKSp1-C or CCKSp1-T (panel b). Half-maximal displacement of Sp1 was obtained with ෂ8-fold surplus of CCKSp1-C and about 16-fold CCKSp1-T. The binding affinity of Sp3 was also about two-fold lower for CCKSp1-T than for CCKSp1-C. We conclude that the CCKSp1-C and CCKSp1-T elements both bind Sp1 and Sp3, although the affinity of the two factors towards CCKSp1-T is slightly lower.
Activation of the CCK promoter by recombinant Sp1 and Sp3 in vivo was examined by co-transfection of pPacSp1 and pPacSp3 and a CCK-100 reporter construct with either the C or the T residue in the core of the Sp1 element. (Figure 3 ). To avoid interference from endogenous Sp1 and Sp3, transfections were performed in Drosophila Schneider cells, that do not express the Sp family of transcription factors. A −194 fragment of the human gastrin promoter was included as a positive control. 9 Sp1 caused a moderate (ෂ2.5 fold)-but similar-dose-dependent activation of the two CCK promoter constructs, whereas Sp3 had no effect on the constructs. The gastrin promoter was activated 7-fold as described previously 9 (data not shown). In order to examine the effect of the C to T transition towards physiological stimuli, human SK-N-MC neuro-Molecular Psychiatry blastoma cells were transfected with CCK-100Sp1-C and CCK-100Sp1-T promoter constructs and incubated with bFGF and forskolin, that stimulate the CCK promoter via activation of the MAP kinase and protein kinase A signalling pathways 10 ( Figure 4 ). The basal transcriptional activities of the two promoter variants were identical, and both constructs exhibited a 2.5-, 5-and 15-fold increase of transcriptional activity after addition of bFGF, forskolin or both agents, respectively. 
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We have characterized the significance of the C −36 to T polymorphism on CCK transcription by means of binding studies in vitro and activation of the promoter with recombinant Sp1 and Sp3 in vivo. Moreover, stimulation of the promoter with physiological stimuli was also examined. As described previously 11 the substitution of cytosine with thymidine in the core of the Sp1 element was followed by a moderate reduction in the binding affinity of both Sp1 and Sp3. However, this substitution did not result in change of either the basal or regulated promoter activity, probably reflecting that binding of Sp1 to the CCK promoter in vivo depends on multiple contacts to co-factors and to the basal transcriptional machinery. In this way, the stability of the transcriptional complex is not severely disturbed by the small reduction in the DNA-binding affinity of Sp1 and Sp3 in vitro. The modest effect of a T substitution is also illustrated by the gastrin promoter that exhibits a fully functional Sp1 GGGTGG element. 9 Moreover, the Sp1 element may not be essential for CCK promoter activity. Sp1 mediated activation of the CCK promoter in Schneider cells is moderate; this may be related to the fact that Sp1 and the TATA binding complex are unlikely to bind simultaneously, since the Sp1 element is located only eight nucleotides upstream from the TATA-box. 12 Finally, regulated CCK transcription depends largely on the association of the CRE/TRE element binding with CREB and members of the AP-1 family of transcription factors. Activation via this element is controlled by the MAP-kinase and the protein kinase A signalling pathways, that are stimulated by growth factors, neuropeptides and transmitters in the central nervous system. The fact that we could not detect a difference in activation between the promoter variants under these physiological conditions strongly suggests that the T transition does not lead to reduced CCK production.
Our results therefore indicate that the CCK polymorphism is unlikely to play a direct role in the pathogenesis of alcoholism or panic disorder. Patients with panic disorder as well as alcoholism have been reported to have reduced concentrations of CCK peptides in the cerebrospinal fluid (CSF), 13 perhaps indicating that the T-polymorphism could be linked to other mutations like the polymorphic 3Ј splice acceptor site of exon 2 in the CCK gene.
14 Alternatively, the T-allele is linked to a mutation in a neighboring gene. Finally, it should be emphasized that measurements of CCK in CSF are still problematic. 15 Due to the elusive pathology of panic disorder and alcoholism it is difficult to identify potential cancidate genes, but future studies may benefit from the application of markers outside the CCK gene.
Materials and methods

Plasmid constructions
The human CCK gene promoter construct CCK-100 consists of a 100-bp 5Ј-promoter fragment inserted into the pCAT vector (Promega, Madison, WI, USA) as recently described. 4 The CCK-100Sp1-T plasmid was constructed by the Quick change Site-directed mutagenese kit (Stratagene, La Jolla, CA, USA) using CCK-100 as template and the oligonucleotides 5Ј-GGCCGACGCGCCGGGTGGGGCTATTTAAGAG-3Ј and 5Ј-CGCGGAAATAGCCCCACCCGGCGCGTCGGCC-3Ј. The expression vectors pPacSp1, 16 pPacSp3 17 and p97b were kind gifts from Robert Tjian (University of California, Berkeley, CA, USA), and Guntram Suske (Philipps Universität Marburg, Germany).
Preparation of nuclear extract and electrophoretic mobility shift assays (EMSAs).
Nuclear extracts from SK-N-MC cells were prepared as described. 18 The protein concentration was determined using the Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA). 19 Four × 10 4 cpm [ 32 P]-␥-ATP labelled double-stranded oligonucleotides, corresponding to the wild-type CCK gene promoter 5Ј-flanking sequence −48 to −19 relative to the transcription start site (5Ј-CGACGCGCCGGGGGGGGCTATT TAAGAGAC-3Ј), or the Sp1-T element (5Ј-CGA CGCGCCGGGTGGGCCTATTTAAGAGAC-3Ј), were incubated with 5 g of nuclear extract in 10 mM HEPES (pH 7.9), 100 mM KCl, 0.05 mM EDTA, 1 mM DTT, 2.5 mM MgCl 2 , 6% glycerol, 2 g of (dl-dC), in a total volume of 20 l for 30 min at room temperature. DNA-protein complexes were analysed on a 4% nondenaturing polyacrylamide gel in 0.5 × TBE buffer (TBE: 130 mM Tris pH 5.8, 89 mM boric acid and 2 mM EDTA) and quantified by phosphoimager counting (Fuji, Tokyo, Japan) for quantitative analysis. For supershift analysis, 1 l of anti-Sp1 antibody or 1 l anti-Sp3 antibody (both from Santa Cruz Biotech, Santa Cruz, CA, USA) were added to the reaction for 60 min at 4°C prior to loading on the gel.
Cell culture and transient transfections
The Drosophila SL2 Schneider cells 20 were maintained in Drosophila Schneider medium (Life Technologies, Gaithersburg, MD, USA) supplemented with 10% fetal calf serum, 1% streptomycin and 1% penicillin at 25°C. Cells were seeded at a density of 3 × 10 6 /100-mm culture dishes approximately 24 h before transfection. DNA were introduced into the cells by the calcium phosphate method as described. 21 Each culture dish received 10 g of CCK-100, CCK-100Sp1-T or gastrin reporter plasmid, different amounts of pPacSp1, pPacSp3, and pBluescript (Stratagene) making a total of 30 g DNA. To normalize CAT activity, cells were co-transfected with 5 g p97b, a vector which expresses the ␤-galactosidase gene and is driven by an Sp1 and Sp3-independent Drosophila promoter. The precipitates were left on the cells for 48 h, before they were harvested for measurement of CAT and ␤-galactosidase activity. Each transfection series was performed with two different plasmid preparations to exclude differences in DNA purity.
Human SK-N-MC neuroblastoma cells were maintained as described. 4 One day before transfection 2.5 × 10 6 SK-N-MC cells were seeded in 100-mm culture dishes. Five g CCK reporter plasmid, 0.5 g pRL-0 (Promega), and pBluescript (Stratagene) to a total of 20 g were co-transfected using the calcium phosphate co-precipitation method. 22 Six hours before harvesting, the cells were stimulated with either 25 ng ml −1 bFGF (Amersham, Arlington Heights, IL, USA), 10 M forskolin (Sigma, St Louis, MO, USA) or both.
CAT, luciferase assays and ␤-galactosidase CAT assay was performed essentially as described. 23 The separation of CAT reaction products was assayed by thin layer chromatography and quantified with a BAS 2000 phosphoimager (Fuji). Values were normalized to luciferase activity performed according to the instructions of the manufacturer (Promega), or to ␤-galactosidase activity as described. 10 
